111 Capital’s Steris STE Stock Holding History

111 Capital’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,149	Closed	-$1.24M	–	676
2025 Q2	$1.24M	Buy	+5,149	New	+$1.2M	0.21%	109

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

111 Capital's STE Position: Q3 2025 in Review

111 Capital sold out of Steris (STE) in Q3 2025, closing a stake of 5,149 shares — an estimated $1.24M sold.

111 Capital first reported a position in STE in Q2 2025 and held it in 1 quarter. The position peaked at $1.24M in Q2 2025. 842 funds tracked by Wall St. Rank hold STE as of Q3 2025.

111 Capital reported no remaining Steris position as of Q3 2025 after selling out during the quarter.
111 Capital sold 5,149 Steris shares in Q3 2025, an estimated $1.24M.
111 Capital first reported a position in Steris in Q2 2025 and held it in 1 quarter.
111 Capital's Steris position peaked at $1.24M in Q2 2025.
842 funds tracked by Wall St. Rank held Steris as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.